AdvisorShares Alpha DNA Equity Sentiment ETF SENT 深 滬
等待開盤 09-24 09:30:00 美东时间
21.2172
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 21.2172
- 總市值 1060.86万
- 52周最高 25.0709
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 21.1024
- 委 比 0.00%
- 總股本 50.00万
- 歷史最高 29.19
- 量 比 0
- 振 幅 0.00%
- 歷史最低 20.16
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Karyopharm Completes Enrollment In Phase 3 Trial Testing New Combo Therapy For Myelofibrosis Patients
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has completed enrollment in the Phase 3 SENTRY trial, which is evaluating
09-10 19:02
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., Sept. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 9:15 a.m. ET on September 9, 2025. Pet...
09-05 04:01
BRP PRESENTS ITS SECOND QUARTER RESULTS FOR FISCAL YEAR 2026
Highlights Revenues of $1,888.2 million, an increase of 4.3% compared to last year; Net income of $57.1 million, an increase of 36.0% compared to last year; Normalized EBITDA [1] of $213.2 m...
08-29 18:00
KEYCORP TO PRESENT AT THE BARCLAYS GLOBAL FINANCIAL SERVICES CONFERENCE
CLEVELAND, Aug. 26, 2025 /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that Randy Paine, Head of Institutional Banking, and Clark Khayat, Chief Financial Officer, will present at the B...
08-26 20:30
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose sharply in pre-market...
08-20 19:24
ITURAN PRESENTS SECOND QUARTER 2025 RESULTS
Record revenue of $86.8 million and added 40,000 net new subscribers in the quarter AZOUR, Israel, Aug. 19, 2025 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN) today announc...
08-19 18:30
Senti Bio Highlights Phase 2 Dose Selection For SENTI-202 CAR-NK Therapy In Virtual Investor Segment
Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it
08-12 21:16
LIONSGATE REPORTS RESULTS FOR FIRST QUARTER FISCAL 2026
Studio Revenue was $556 Million; Net Loss From Continuing Operations Attributable to Shareholders was $94.0 Million or $0.35 Diluted Net Loss Per Share Adjusted Net Loss from Continuing Oper...
08-08 04:05
ScanTech AI Systems Enters Into A Non-Binding Letter Of Intent With Visiontec Systems For The Planned Purchase Of Additional Sentinel Fixed Gantry CT Inspection Systems
Atlanta, GA, July 28, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today announced that it has
07-29 04:11
Banco Macro S.A. Announces Pricing of Notes Offering Under Medium Term Note Program
BUENOS AIRES, Argentina, June 17, 2025 /PRNewswire/ -- Banco Macro S.A. (NYSE: ...
06-18 08:36
